ConductScience.org, home

Paper28006993

The structural modification of natural products for novel drug discovery.

Yao H and 4 others. Expert Opin Drug Discov, 2017. Cited by 189 papers, by iCite.

Cite this record

ConductScience Library. The structural modification of natural products for novel drug discovery. Papers, record 28006993. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28006993

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The structural modification of natural products for novel drug discovery.
PubMed
Journal
Expert Opin Drug Discov
PubMed
Year
2017
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
189
iCite
Relative citation ratio, by iCite
8.33
iCite
Revised in PubMed
2022-04-08
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yao HHong
2Liu JJunkai
3Xu SShengtao
4Zhu ZZheying
5Xu JJinyi

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biological ProductsMajor topic
Drug DesignMajor topic
Drug DiscoveryMajor topic
Drug Stability
Humans
Solubility

Cited by85

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 189 citations.

PMIDTitleJournalYearIn PapersSource
42972149From structure prediction to ligand-target recognition: expanding the reach of AlphaFold in natural product research.Nat Prod Bioprospect2026https://conductscience.org/library/papers/42972149PubMed
42329132Modular Framework for 3D Molecular Generation in Computational Chemistry Applications.J Am Chem Soc2026https://conductscience.org/library/papers/42329132PubMed
42253922Progress in Natural Products Target Discovery Technology.MedComm (2020)2026https://conductscience.org/library/papers/42253922PubMed
42249117Divergent and precise alkaloid remodelling with a small suite of reactions.Nat Chem2026https://conductscience.org/library/papers/42249117PubMed
42223756Sesamol derivatives bearing a quinazolin moiety: synthesis, antifungal efficacy against tea plant pathogens, and mechanistic insights.Nat Prod Bioprospect2026https://conductscience.org/library/papers/42223756PubMed
42216452A Bio-Based Chiroptical Overcrowded Alkene From Flavanone: Photoreactivity and Theoretical Investigation.Chemistry2026https://conductscience.org/library/papers/42216452PubMed
42074289Targeting the NLRP3 Inflammasome in Atherosclerosis: A Review of Natural Products and Their Molecular Mechanisms.Int J Mol Sci2026https://conductscience.org/library/papers/42074289PubMed
41743134Anti-GPV activity of Lactobacillus-fermented traditional Chinese medicines.Front Microbiol2026https://conductscience.org/library/papers/41743134PubMed
41709327Investigating the impact and mechanism of Licochalcone B derivative CTG12 on NLRP3 inflammasome.Cell Commun Signal2026https://conductscience.org/library/papers/41709327PubMed
41660905Clausenidin from Clausena excavata Burm. causes Apoptosis of Liver Cancer in Mice.Asian Pac J Cancer Prev2026https://conductscience.org/library/papers/41660905PubMed
41585642Creation and Functional Evaluation of a Novel Antioxidant Compound via UV-Induced Structural Transformation of Epicatechin from White Wine Pomace.ACS Omega2026https://conductscience.org/library/papers/41585642PubMed
41524971AI-driven peptide discovery for endometrial cancer: deep generative modeling and molecular simulation in the big data era.J Comput Aided Mol Des2026https://conductscience.org/library/papers/41524971PubMed
41523743Spectrochemical, medicinal, and toxicological studies of moxifloxacin and its novel analogs: a quantum chemistry and drug discovery approach.RSC Adv2026https://conductscience.org/library/papers/41523743PubMed
41345178In-silico investigations of bioactive compounds from ginger against Lassa fever virus nucleoprotein.Sci Rep2025https://conductscience.org/library/papers/41345178PubMed
41007298Therapeutic Potential of Natural Compounds for Brain Ischemia-Reperfusion Injury.Biology (Basel)2025https://conductscience.org/library/papers/41007298PubMed
40873643Emerging Target Discovery Strategies Drive the Decoding of Therapeutic Power of Natural Products and Further Drug Development: A Case Study of Celastrol.Exploration (Beijing)2025https://conductscience.org/library/papers/40873643PubMed
40808802Substituted 1,4-naphthoquinones for potential anticancer therapeutics: In vitro cytotoxic effects and QSAR-guided design of new analogs.Comput Struct Biotechnol J2025https://conductscience.org/library/papers/40808802PubMed
40510420Targeting programmed cell death with natural products: a potential therapeutic strategy for diminished ovarian reserve and fertility preservation.Front Pharmacol2025https://conductscience.org/library/papers/40510420PubMed
40478370Bridging chemical space and biological efficacy: advances and challenges in applying generative models in structural modification of natural products.Nat Prod Bioprospect2025https://conductscience.org/library/papers/40478370PubMed
401411174(3H)-Quinazolinone: A Natural Scaffold for Drug and Agrochemical Discovery.Int J Mol Sci2025https://conductscience.org/library/papers/40141117PubMed

See all 85 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28006993

GET https://conductscience.org/api/papers/v1/28006993/cited_by?page=2